Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 2

Vitamin D receptor polymorphisms and bone health after kidney transplantation

Pages
802–812
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Certain VDR gene polymorphisms are associated with a higher risk for bone diseases after kidney transplantation.Key words: Kidney transplantation, VDR polymorphisms, osteoporosis, avascular necrosis, persistent hyperparathyroidism

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Bone disease is one of the most prominent complications after kidney transplantation.
📊
Key Findings & Data:Materials and methods: The study consists of 234 kidney allograft recipients with a minimum follow-up of five years after kidney transplantation.
💡
Conclusion & Impact:Conclusion: Certain VDR gene polymorphisms are associated with a higher risk for bone diseases after kidney transplantation.Key words: Kidney transplantation, VDR polymorphisms, osteoporosis, avascular necrosis, persistent hyperparathyroidism
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Bone disease is one of the most prominent complications after kidney transplantation. Bone diseases include osteoporosis, persistent secondary hyperparathyroidism, and avascular necrosis (AVN). We investigated the relationship between the polymorphisms of the vitamin D receptor (VDR) gene and bone diseases occurring after kidney transplantation. Materials and methods: The study consists of 234 kidney allograft recipients with a minimum follow-up of five years after kidney transplantation. Patients with glomerular filtration rates less than 30 mL/min/1.73m2, a history of parathyroidectomy, bisphosphonate use pre- or post-transplantation, and cinacalcet use posttransplantation excluded. We evaluated associations between the polymorphisms of the VDR gene (BsmI, TaqI, ApaI, FokI, and Cdx2), the first-year bone mineral density (BMD) scores, persistent secondary hyperparathyroidism, and AVN. Results: Patients with low BMD scores were significantly younger (P = 0.03) and had higher intact parathormone (iPTH) levels (P = 0.03). Cdx2 TT genotype significantly increases the risk of low BMD scores (OR: 3.34, P = 0.04). Higher phosphate levels were protective against abnormal BMD scores (OR: 0.53; P = 0.03). Patients with persistent hyperparathyroidism had significantly longer dialysis vintage and higher pretransplantation iPTH levels (P = 0.02 and P < 0.001, respectively). Cdx2, CT/TT, and ApaI CA/AA genotypes significantly increase the risk of persistent hyperparathyroidism (OR: 6.81, P < 0.001, OR: 23.32, P < 0.001, OR:4.01, P = 0.02, and OR: 6.30, P = 0.01; respectively). BsmI CT/TT genotypes were found to increase AVN risk with an HR of 3.48 (P = 0.03). Higher hemoglobin levels were also found to decrease AVN risk with an HR of 0.76 (P = 0.05). Conclusion: Certain VDR gene polymorphisms are associated with a higher risk for bone diseases after kidney transplantation.Key words: Kidney transplantation, VDR polymorphisms, osteoporosis, avascular necrosis, persistent hyperparathyroidism

🔖

Cite This Article

GÖNEN, S., TÜKÜN, A., YETER, H., HELVACI, Ö., KORUCU, B., GÜZ, G., ARINSOY, T. (2022). Vitamin D receptor polymorphisms and bone health after kidney transplantation. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 2, 802–812. https://ajindex.com/articles/609546

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine 1999; 341 (23): 1725-1730. doi: 10.1056/NEJM199912023412303 2. Hruska KA, Teitelbaum SL. Renal osteodystrophy. New England Journal of Medicine 1995; 333 (3): 166-175. doi: 10.1056/ NEJM199507203330307 3. Dounousi E, Leivaditis K, Eleftheriadis T, Liakopoulos V. Osteoporosis after renal transplantation. International Urology and Nephrology 2015; 47 (3): 503-511. doi: 10.1007/s11255- 014-0862-3 4. Park W, Han S, Choi B, Park C, Yang C et al. Progression of osteoporosis after kidney transplantation in patients with endstage renal disease. Transplantation Proceedings2017; 49 (5): 1033-1037. doi: 10.1016/j.transproceed.2017.03.038 5. Cunningham J. Posttransplantation bone disease. Transplantation 2005; 79 (6): 629-634. doi: 10.1097/01. tp.0000149698.79739.ef 6. Ozel L, Ata P, Ozel M, Toros A, Kara M et al. Risk factors for osteoporosis after renal transplantation and effect of vitamin D receptor Bsm I polymorphism. Transplantation Proceedings 2011; 43 (3): 858-862. doi: 10.1016/j.transproceed.2011.02.075 7. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrology Dialysis Transplantation 2004; 19 (5): 1281-1287. doi: 10.1093/ndt/gfh128 8. Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. American Journal of Kidney Diseases 1998; 32 (3): 464-469. doi: 10.1053/ajkd.1998. v32.pm9740163 9. Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 2013; 154 (3): 1008-1020. doi: 10.1210/en.2012-1542 10. Pouya F, Kerachian MA. Avascular necrosis of the femoral head: are any genes involved? Archives of Bone and Joint Surgery 2015; 3 (3): 149. doi: 10.22038/ABJS.2015.4294 11. World Health Organization (WHO). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992].
  2. Geneva, Switzerland: WHO; 1994. 12. Lewiecki EM, Binkley N, Morgan SL, Shuhart CR, Camargos BM et al. Best practices for dual-ener